Dror Bashan
CEO, President at Protalix BioTherapeutics, Inc. (PLX)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+21.7%
vs. S&P 500+26.2%
Beat the market100%
Paper profit on buys+$54K
Total bought / sold$101K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 23SEC | PLXProtalix BioTherapeutics, Inc. | Buy | 56,000188,516 held (+42%) | $1.81 | $101K | +53.6% |
- Buy
CEO, President Dror Bashan bought $101K of PLX at $1.81 — first open-market purchase in our records; raises the stake by 42%.